[ad_1]
Table of Contents
NineSigma representing Mitsui Chemicals, Inc., a major global chemical manufacturer, seeks a potential development partner to jointly elucidate the mechanism of expressed and improved antibacterial/antiviral activity on a solid surface.
Pathogen particle – illustrative rendering. Image credit: CDC via Unsplash, free license
The client has developed a technology to form an uneven nano-structure on a solid surface and confirmed that this physical structure enables the continuous expression of high antibacterial/antiviral activity without using cleaning agents such as a surfactant or antibacterial agents such as a photocatalyst.
On the other hand, the client is faced with the problem that no verification technology or knowledge about the elucidation of mechanism exists. The client looks forward to hearing proposals from organizations who will be able to make and verify a hypothesis for the mechanism in discussion with the client by around March 2024.
Working in a biotechnology lab, antiviral technologies – illustrative photo. Image credit: CDC
The client has established a technology for the continuous expression of high antibacterial/antiviral activity by forming a fine uneven structure on the surface of a solid metal. However, the client faces the problem of no verification technology or knowledge about the mechanism of expressed or improved antibacterial/antiviral activity.
Submissions to this Challenge just be received by Jul 5, 2023.
Source: NineSights
Featured Post
[ad_2]
Source link
